The use of baselines in clinical trials of bronchodilators
- 1 November 1989
- journal article
- review article
- Published by Wiley in Statistics in Medicine
- Vol. 8 (11) , 1339-1350
- https://doi.org/10.1002/sim.4780081106
Abstract
Two important qualities of controlled clinical trials are that they reduce dependence on historical standards for evaluating therapy and separate the effect of treatment from the confounding influence of time. Whatever the theory of the clinical trial, however, time has not easily been banished from the analysis of medical experiments in practice, and many doctors still prefer to evaluate treatments by comparing now with then rather than treatment with control. This is especially so in trials of bronchodilators in the treatment of asthma where, it is shown, baselines are used in ways which can increase the variability of measurement and even bias the results.Keywords
This publication has 14 references indexed in Scilit:
- Covariate imbalance and random allocation in clinical trialsStatistics in Medicine, 1989
- Methods for assessing whether change depends on initial valueStatistics in Medicine, 1988
- The analysis of data from 2 × 2 cross‐over trials with baseline measurementsStatistics in Medicine, 1987
- Comparability of Randomised GroupsJournal of the Royal Statistical Society: Series D (The Statistician), 1985
- Further Comparative Analyses of Pretest-Posttest Research DesignsThe American Statistician, 1983
- Development of statistical analysis for single dose bronchodilatorsControlled Clinical Trials, 1981
- Inhibitory Effect of KWD 2131, Terbutaline, and DSCG on the Immediate and Late Allergen-Induced BronchoconstrictionAllergy, 1981
- Standardization of bronchial inhalation challenge proceduresJournal of Allergy and Clinical Immunology, 1975
- Statistical methods for the identification and use of prognostic factorsInternational Journal of Cancer, 1974
- Interpretation of Adjusted Treatment Means and Regressions in Analysis of CovarianceBiometrics, 1957